Focus: Kodiak Sciences is a clinical-stage ophthalmology biotech focused on long-acting retinal medicines for vision-threatening diseases. The company is advancing a pipeline of novel therapeutics targeting major indications including diabetic retinopathy, age-related macular degeneration, and inflammatory macular edema.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Kodiak Sciences to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Kodiak Sciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Kodiak Sciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub